Salidroside alleviates Aβ1–42-induced ferroptosis in human neuroblastoma cells by AKT/GSK-3β activation via inhibiting VDAC1
Phytomedicine Plus · 2025-08 · 5 (3) · 100802
DOI: 10.1016/j.phyplu.2025.100802 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytomedicine Plus, 2025-08. Verfasst von Bensi Zhang und 7 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Faculty of Medicine, Chiang Mai University, Yunnan Provincial Science and Technology Department.
Abstract (Originalsprache)
Background
Alzheimer's disease (AD) is a degenerative neurological disease, and SH-SY5Y cells play an important role in the pathogenesis of AD. Salidroside is the main active ingredient of Rhodiola rosea L.
Purpose
The aim of this study was to investigate the effect of salidroside on the induction of ferroptosis in SH-SY5Y cells by Aβ1–42.
Methods
Aβ1–42-induced SH-SY5Y cells were used to construct an AD cell model, and cell viability was measured by CCK-8. The expression of ferroptosis-related proteins, VDAC1, and AKT/GSK-3β signaling pathway-related proteins was detected by western blotting; the Fe²⁺ content of cells was determined by an iron content assay kit; the level of ROS in cells was detected by immunofluorescence; and apoptosis was detected by flow cytometry.
Results
This research showed that salidroside alleviated Aβ1–42-induced ferroptosis in SH-SY5Y cells at an optimal concentration of 30 mM. The expression of GPX4 and FTH1 increased, and the expression of IREB2 decreased after salidroside treatment. The apoptosis rate decreased, as did the intracellular Fe²⁺ content and the level of ROS. After transfection with si-VDAC1, the trend of change was similar to that after salidroside treatment. Furthermore, treatment with an AKT inhibitor and AKT activator demonstrated the involvement of the AKT/GSK-3β signaling pathway in the induction of ferroptosis in SH-SY5Y cells by Aβ1–42.
Conclusion
The findings suggest that salidroside alleviates cellular ferroptosis by AKT/GSK-3β pathway activation via inhibiting VDAC1.
Förderung
- Faculty of Medicine, Chiang Mai University
- Yunnan Provincial Science and Technology Department
Zitieren
APA
Zhang, B., Zhang, X., Treebuphachatsakul, W., Pantan, R., Kampan, N., Phatsara, M., Shi, C., & Narakornsak, S. (2025). Salidroside alleviates Aβ1–42-induced ferroptosis in human neuroblastoma cells by AKT/GSK-3β activation via inhibiting VDAC1. Phytomedicine Plus, 5(3), 100802. https://doi.org/10.1016/j.phyplu.2025.100802
Vancouver
Zhang B, Zhang X, Treebuphachatsakul W, Pantan R, Kampan N, Phatsara M, et al. Salidroside alleviates Aβ1–42-induced ferroptosis in human neuroblastoma cells by AKT/GSK-3β activation via inhibiting VDAC1. Phytomedicine Plus. 2025;5(3):100802. doi:10.1016/j.phyplu.2025.100802
BibTeX
@article{Zhang2025,
author = {Zhang, Bensi and Zhang, Xiujun and Treebuphachatsakul, Waleephan and Pantan, Rungusa and Kampan, Natnicha and Phatsara, Manussabhorn and Shi, Chun and Narakornsak, Suteera},
title = {Salidroside alleviates Aβ1–42-induced ferroptosis in human neuroblastoma cells by AKT/GSK-3β activation via inhibiting VDAC1},
journal = {Phytomedicine Plus},
year = {2025},
volume = {5},
number = {3},
pages = {100802},
doi = {10.1016/j.phyplu.2025.100802}
}
EUVIMED